Hyperthyroidism is one of the most common endocrine diseases in older cats. Treatment options including medication, diet, radioiodine, and surgery have different welfare profiles for individual cats.
Cat hyperthyroid welfare management requires individualized decision-making that considers the cat's temperament, owner capacity, and concurrent health conditions. Radioiodine provides the best long-term welfare outcome for most cats but requires hospitalization until radiation levels fall. Daily medication is equally effective but imposes twice-daily handling that severely stresses some cats, potentially causing more welfare harm than the disease itself. Diet management is welfare-friendly for compliant cats but impossible for cats with access to other food sources. The welfare conversation must be honest about what each option demands of both cat and owner, rather than assuming the medically superior option is always the welfare-optimal choice for a specific animal.